Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T T Warner

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Annals of Neurology|July 14, 2000
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophyR Lodi, A H Schapira, D Manners, et al.
Neurology|August 23, 2006
Increased rate of whole-brain atrophy over 6 months in early Huntington diseaseS M D Henley, C Frost, D G MacManus, et al.
Neurology|December 28, 2006
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystoniaS J Cano, J C Hobart, M Edwards, et al.
Neurology|July 23, 2003
A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegiaP A Wilkinson, A H Crosby, C Turner, et al.
American Journal of Human Genetics|June 5, 2001
The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtypeH Patel, P E Hart, T T Warner, et al.
Human Molecular Genetics|November 7, 2000
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicityS J Tabrizi, M Orth, J M Wilkinson, et al.
Neurology|May 11, 2005
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS studyS J Tabrizi, A M Blamire, D N Manners, et al.
Neurology|July 9, 2003
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot studyS J Tabrizi, A M Blamire, D N Manners, et al.
Neuropathology and Applied Neurobiology|July 29, 2020
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementiaD Hansen, H Ling, T Lashley, et al.
Neurology|November 10, 2004
Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58)S J Cano, T T Warner, J M Linacre, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Annals of Neurology|July 14, 2000
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophyR Lodi, A H Schapira, D Manners, et al.
Neurology|August 23, 2006
Increased rate of whole-brain atrophy over 6 months in early Huntington diseaseS M D Henley, C Frost, D G MacManus, et al.
Neurology|December 28, 2006
CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystoniaS J Cano, J C Hobart, M Edwards, et al.
Neurology|July 23, 2003
A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegiaP A Wilkinson, A H Crosby, C Turner, et al.
American Journal of Human Genetics|June 5, 2001
The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtypeH Patel, P E Hart, T T Warner, et al.
Human Molecular Genetics|November 7, 2000
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicityS J Tabrizi, M Orth, J M Wilkinson, et al.
Neurology|May 11, 2005
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS studyS J Tabrizi, A M Blamire, D N Manners, et al.
Neurology|July 9, 2003
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot studyS J Tabrizi, A M Blamire, D N Manners, et al.
Neuropathology and Applied Neurobiology|July 29, 2020
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementiaD Hansen, H Ling, T Lashley, et al.
Neurology|November 10, 2004
Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58)S J Cano, T T Warner, J M Linacre, et al.
Pageof 5